Patents by Inventor Paul G. Wyatt

Paul G. Wyatt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5252575
    Abstract: Compounds of formula (I) and pharmaceutically acceptable salts thereof: ##STR1## wherein R.sub.1 is hydrogen or hydroxy; andR.sub.2 is C.sub.1-6 alkyl;which are pro-drugs for 9-(3-hydroxyprop-1-oxy)guanine having antiviral activity, a process for their preparation and their use as pharmaceuticals.
    Type: Grant
    Filed: May 21, 1992
    Date of Patent: October 12, 1993
    Assignee: Beecham Group p.l.c.
    Inventors: Michael R. Harnden, Paul G. Wyatt, Leslie J. A. Jennings
  • Patent number: 5159076
    Abstract: Compounds of formula (II): ##STR1## wherein R.sub.4 ' is R.sub.4 whereinR.sub.4 is hydrogen, hydroxy, amino or OR.sub.5 whereinR.sub.5 is C.sub.1-6 alkyl, phenyl or phenyl C.sub.1-2 alkyl either of which phenyl moieties may be substituted by one or two halo, C.sub.1-4 alkyl or C.sub.1-4 alkoxy groups;or R.sub.4 ' is a group or atom convertible to R.sub.4 ; andR.sub.x is amino or protected amino;which are useful intermediates in the preparation of purine derivatives having antiviral activity.
    Type: Grant
    Filed: January 2, 1990
    Date of Patent: October 27, 1992
    Assignee: Beecham Group p.l.c.
    Inventor: Paul G. Wyatt
  • Patent number: 4965270
    Abstract: Compounds of formula (I), and pharmaceutically acceptable salts thereof: ##STR1## wherein R.sub.1 is hydrogen or CH.sub.2 OH;R.sub.2 is hydrogen or, when R.sub.1 is hydrogen, hydroxy or CH.sub.2 OH;R.sub.3 is CH.sub.2 OH or, when R.sub.1 and R.sub.2 are both hydrogen, CH(OH)CH.sub.2 OH;R.sub.4 is hydrogen, hydroxy, amino or OR.sub.5 whereinR.sub.5 is C.sub.1-6 alkyl, phenyl or phenyl C.sub.1-2 alkyl either of which phenyl moieties may be substituted by one or two halo, C.sub.1-4 alkyl or C.sub.1-4 alkoxy groups;and in which any OH groups in R.sub.1, R.sub.2 and R.sub.3 may be in the form of O-acyl, phosphate, cyclic acetal or cyclic carbonate derivatives thereof; having antiviral activity.
    Type: Grant
    Filed: November 7, 1989
    Date of Patent: October 23, 1990
    Assignee: Beecham Group p.l.c.
    Inventors: Michael R. Harnden, Paul G. Wyatt, Stuart Bailey
  • Patent number: 4910307
    Abstract: A process for the preparation of compounds of formula (I), and pharmaceutically acceptable salts thereof: ##STR1## wherein R.sub.1 is hydrogen or CH.sub.2 OH;R.sub.2 is hydrogen or, (when R.sub.1 is hydrogen), hydroxy or CH.sub.2 OH;R.sub.3 is CH.sub.2 OH or, (when R.sub.1 and R.sub.2 are both hydrogen), CH(OH)CH.sub.2 OH;R.sub.4 is hydrogen, hydroxy, amino or OR.sub.5whereinR.sub.5 is C.sub.1-6 alkyl, phenyl or phenyl C.sub.1-2 alkyl either of which phenyl moieties may be substituted by one or two halo, C.sub.1-4 alkyl or C.sub.1-4 alkoxy groups;and in which any OH groups in R.sub.1, R.sub.2 and/or R.sub.3 may be in the form of O-acyl, phosphate, cyclic acetal or cyclic carbonate derivatives thereof;which process comprises the reaction of a compound of formula (II): ##STR2## wherein R.sub.4 ' is R.sub.4 or a group or atom convertible thereto and R.sub.x is amino or protected amino; with a compound of formula (III):R.sub.3 'CHR.sub.2 'CHR.sub.1 'Q (III)wherein Q is a leaving group and R.sub.1 ', R.sub.
    Type: Grant
    Filed: October 20, 1988
    Date of Patent: March 20, 1990
    Assignee: Beecham Group p.l.c.
    Inventor: Paul G. Wyatt